Abstract | BACKGROUND: METHODOLOGY/PRINCIPAL FINDINGS: We report the identification of a new target of EWS/WT1, ENT4 (equilibrative nucleoside transporter 4) which encodes a pH-dependent adenosine transporter. ENT4 is transcriptionally activated by both isoforms of EWS/WT1 as evidenced by promoter-reporter and chromatin immunoprecipitation (ChIP) analyses. Furthermore, ENT4 is highly and specifically expressed in primary tumors of DSRCT as well as in a DSRCT cell line, JN-DSRCT-1. Treatment of JN-DSRCT-1 cells with adenosine analogs, such as 2-chloro-2'-deoxyadenosine (2-CdA), resulted in an increased cytotoxic response in dose- and pH-dependent manner. CONCLUSIONS/SIGNIFICANCE: Our detailed analyses of a novel target of EWS/WT1 in DSRCT reveal an insight into the oncogenic mechanism of EWS-fusion chromosomal translocation gene products and provide a new marker for DSRCT. Furthermore, identification of ENT4 as a highly expressed transcript in DSRCT may represent an attractive pathway for targeting chemotherapeutic drugs into DSRCT.
|
Authors | Hongjie Li, Gromoslaw A Smolen, Lisa F Beers, Li Xia, William Gerald, Joanne Wang, Daniel A Haber, Sean Bong Lee |
Journal | PloS one
(PLoS One)
Vol. 3
Issue 6
Pg. e2353
(Jun 04 2008)
ISSN: 1932-6203 [Electronic] United States |
PMID | 18523561
(Publication Type: Journal Article, Research Support, N.I.H., Intramural)
|
Chemical References |
- DNA Primers
- Equilibrative Nucleoside Transport Proteins
- RNA-Binding Protein EWS
- SLC29A4 protein, human
- WT1 Proteins
- Adenosine
|
Topics |
- Adenosine
(metabolism)
- Base Sequence
- Carcinoma, Small Cell
(metabolism, pathology)
- Cell Line, Tumor
- Chromatin Immunoprecipitation
- DNA Primers
- Dose-Response Relationship, Drug
- Equilibrative Nucleoside Transport Proteins
(genetics, metabolism)
- Humans
- Hydrogen-Ion Concentration
- Promoter Regions, Genetic
- Protein Transport
- RNA-Binding Protein EWS
(metabolism)
- Reverse Transcriptase Polymerase Chain Reaction
- WT1 Proteins
(metabolism)
|